development - International Pharmaceutical Industry

Volume 9 Issue 4

Quality by Design in the Development: Benefit or Bureaucratic Burden?

Petra Botzem and Dr Thomas Hille of LTS Lohmann answer this provoking question in their paper on the ICH guideline Q8, with focus on Transdermal Delivery Systems (TD...

4 January 2018 Volume 9 Issue 4 benefit | burden

Continue Reading →

Volume 9 Issue 4

Early Interventions to Reduce the Impact of Immunogenicity on the Development of Biopharmaceuticals

The development of biological therapeutics has led to remarkable clinical benefits in many indications. But, despite this success, the induction of anti-drug antibod...

4 January 2018 Volume 9 Issue 4 biopharmaceuticals | development

Continue Reading →

Volume 9 Issue 4

What Clinical Teams Should Know about Changing Trial Logistics and How they will Affect Development – PART 2

As we shift to what has been described as “an Amazonlike culture”, sponsors want the same opportunity to track shipments in real time and to obtain real-time data th...

4 January 2018 Volume 9 Issue 4 affect | changing

Continue Reading →

News

Almac Group Receives Annual Industrial Award from the Institute of Chemistry of Ireland

Almac Group, the global contract development and manufacturing organisationis delighted to announce Professor Tom Moody, VP Technology Development & Commerc...

5 December 2017 News award | biocatalysis

Continue Reading →

News

STA Pharmaceutical Sees Rapid Growth in MAH Programs in China

STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid uptake in companies with intent to market their products...

1 December 2017 News API | CDMA

Continue Reading →

News

CRUK Manchester Institute to set up major base at Alderley Park

Alderley Park’s position as a key asset in the North of England has been underlined by confirmation that it is to be the interim home for the Cancer Research UK Manc...

28 November 2017 News cancer | development

Continue Reading →

News

Sanofi and Principia agree to develop MS drug candidate

Sanofi will develop Principia Biopharma Inc.'s experimental oral treatment that shows promise in multiple sclerosis (MS) and, potentially, other central nervous syst...

9 November 2017 News autoimmune | central nervous system

Continue Reading →

News

IDBS takes Bioprocess Execution Solution to the Cloud

IDBS announces the release of its latest Bioprocess Execution (BPES) informatics solution. Leveraging the IDBS E-WorkBook Cloud platform, the solution provides an ou...

9 November 2017 News bioprocess | cell

Continue Reading →